Senti Biosciences, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Senti Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2021 to Q3 2024.
  • Senti Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $668K, a 63.3% increase year-over-year.
  • Senti Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $5.41M, a 50.9% decline year-over-year.
  • Senti Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $11.7M, a 24.9% decline from 2022.
  • Senti Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $15.6M, a 578% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $5.41M $668K +$259K +63.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $5.15M -$776K -$4.21M -123% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $9.36M $1.26M -$2.33M -64.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $11.7M $4.26M +$676K +18.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $11M $409K -$1.68M -80.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $12.7M $3.43M -$5.79M -62.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $18.5M $3.59M +$2.93M +443% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $15.6M $3.59M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $2.09M +$1.46M +234% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $9.23M +$8.66M +1541% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $661K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 $626K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $562K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.